Hahn Loeser & Parks LLP
Sherry L. Rollo has handled several high-profile cases as an experienced litigator and licensed patent attorney. Sherry represents clients in domestic and international matters involving patents, trade secrets, trademarks, unfair competition, copyrights and associated licensing issues. In addition, Sherry assists clients in implementing trade secrets audit programs, strategies for conducting effective exit interviews and recovering computer forensic evidence.
She counsels clients in a variety of industries, including cases related to ethanol processing, recycling and industrial resource recovery, camera phones, dental instruments, ultrasonic laser seam welding, precision cutting tools, health care management systems, agricultural machinery, plastic films, aluminum extrusions and electric motors.
Sherry regularly appears in courts across the country, including popular patent venues such as the Northern District of Illinois, District of Delaware, District of New Jersey and Southern District of New York, as well as the Court of Appeals for the Federal Circuit.
Further, Sherry has significant experience counseling clients in transactional matters, including patent protection, portfolio management and licensing. She represents clients large and small in technical areas spanning pharmaceuticals, ethanol processing, recycling and industrial resource recovery, camera phones, dental instruments, ultrasonic laser seam welding, medical devices, precision cutting tools, healthcare management systems, agricultural machinery, plastic films, aluminum extrusions and electric motors. In a recent success, she obtained a permanent injunction on behalf of a company using a catalytic activated vacuum distillation process for extracting by-products, such as carbon, diesel fuel and energy-rich gasses, from recycled tires.
She has been involved in numerous high-profile pharmaceutical Hatch Waxman Act/Abbreviated New Drug Application (ANDA) litigation at both the trial and appellate levels. Some of her more notable cases involved the pharmaceutical products Actonel®, Antara®, Boniva®, Uroxatral®, Eloxatin®, Ultracet®, Omnaris®, Benicar®, Lotrel®, Zometa®, Reclast®, Treanda®, and Plavix®. In addition, Sherry advises clients on Food and Drug Administration marketing exclusivities arising out of ANDA patent litigation, as well as IPRs and post grant proceedings at the U.S. Patent Office.
Sherry’s trademark and copyright experience includes litigating in district court and arguing before the Trademark Trial and Appeal Board on behalf of several major healthcare providers and healthcare insurance providers. She also has written several articles relating to the protection of trademarks in the healthcare industry and related data protection and issues relating to the Health Insurance Portability and Accountability Act.